February 20, 2020

Conduent

Q4 2019

Earnings Results

Cautionary Statements

Forward-Looking Statements

This document contains "forward-looking statements", as defined in the Private Securities Litigation Reform Act of 1995, that involve risks and uncertainties. These statements can be identified by the fact that they do not relate strictly to historical or current facts, but rather are based on current expectations, estimates, assumptions and projections about the business process outsourcing industry and our business and financial results. Forward-looking statements often include words such as "anticipates," "estimates," "expects," "projects," "intends," "plans," "believes," "aim," and words and terms of similar substance in connection with discussions of future operating or financial performance. As with any projection or forecast, forward-looking statements are inherently susceptible to uncertainty and changes in circumstances. Our actual results may vary materially from those expressed or implied in our forward-looking statements. Accordingly, undue reliance should not be placed on any forward-looking statement made by us or on our behalf.

Important factors and uncertainties that could cause our actual results to differ materially from those in our forward-looking statements include, but are not limited to: government appropriations and termination rights contained in our government contracts; risk and impact of potential goodwill and other asset impairments; our ability to renew commercial and government contracts, including contracts awarded through competitive bidding processes; our ability to recover capital and other investments in connection with our contracts; our ability to attract and retain necessary technical personnel and qualified subcontractors; our ability to deliver on our contractual obligations properly and on time; competitive pressures; our significant indebtedness; changes in interest in outsourced business process services; our ability to obtain adequate pricing for our services and to improve our cost structure; claims of infringement of third-party intellectual property rights; the failure to comply with laws relating to individually identifiable information, and personal health information and laws relating to processing certain financial transactions, including payment card transactions and debit or credit card transactions; breaches of our information systems or security systems or any service interruptions; our ability to estimate the scope of work or the costs of performance in our contracts; our continuing emphasis on and shift toward technology-led digital transactions; customer decision-making cycles and lead time for customer commitments; our ability to collect our receivables, including those for unbilled services; a decline in revenues from, or a loss of, or a reduction in business from, or failure of significant clients; fluctuations in our non-recurring revenue; our failure to maintain a satisfactory credit rating; our ability to attract and retain key employees; increases in the cost of telephone and data services or significant interruptions in such services; our failure to develop new service offerings; our ability to modernize our information technology infrastructure and consolidate data centers; our ability to comply with data security standards; our ability to receive dividends or other payments from our subsidiaries; changes in tax and other laws and regulations; changes in government regulation and economic, strategic, political and social conditions; and other factors that are set forth in the "Risk Factors" section, the "Legal Proceedings" section, the "Management's Discussion and Analysis of Financial Condition and Results of Operations" section and other sections in our Annual Reports on Form 10-K, as well as in our Quarterly Reports on Form 10-Q and Current Reports on Form 8-K filed with or furnished to the Securities and Exchange Commission. Any forward-looking statements made by us in this presentation speak only as of the date on which they are made. We are under no obligation to, and expressly disclaim any obligation to, update or alter our forward-looking statements, whether as a result of new information, subsequent events or otherwise.

Non-GAAP Financial Measures

We have reported our financial results in accordance with U.S. generally accepted accounting principles (GAAP). In addition, we have discussed our financial results using non-GAAP measures. We believe these non-GAAP measures allow investors to better understand the trends in our business and to better understand and compare our results. Accordingly, we believe it is necessary to adjust several reported amounts, determined in accordance with GAAP, to exclude the effects of certain items as well as their related tax effects. Management believes that these non-GAAP financial measures provide an additional means of analyzing the results of the current period against the corresponding prior period. However, these non-GAAP financial measures should be viewed in addition to, and not as a substitute for, the Company's reported results prepared in accordance with U.S. GAAP. Our non-GAAP financial measures are not meant to be considered in isolation or as a substitute for comparable U.S. GAAP measures and should be read only in conjunction with our Consolidated Financial Statements prepared in accordance with U.S. GAAP. Our management regularly uses our supplemental non-GAAP financial measures internally to understand, manage and evaluate our business and make operating decisions, and providing such non- GAAP financial measures to investors allows for a further level of transparency as to how management reviews and evaluates our business results and trends. These non-GAAP measures are among the primary factors management uses in planning for and forecasting future periods. Compensation of our executives is based in part on the performance of our business based on certain of these non-GAAP measures.

2

Key Highlights

Q4 / FY

Financials(1)

Strategic &

Operational

Updates

  • Adj. Revenue: at top end of guidance ranges
    • Q4'19 $1,099M; down (6.7)% Y/Y (ex divestitures), down (6.5)% in CC
    • FY'19 $4,431M; down (4.5)% Y/Y (ex divestitures), down (4.0)% in CC
  • Adj. EBITDA: in-line with mid-point of guidance range
    • Q4'19 $130M, down (13.3)% Y/Y (ex divestitures)
    • FY'19 $493M down (7.9)% Y/Y (ex divestitures)
  • FY 2020 Guidance: Establishing FY 2020 Revenue and Adj. EBITDA margin guidance ranges
  • Continued progress on growth, quality, and efficiency transformational pillars
    • Continue to see early indications of technology incident rate and duration improvement
    • Net Promoter Score and anecdotal indicators showing initial improvement in client satisfaction
    • Additional progress made in attracting strong talent to drive transformation
    • Q1'20 new business signings expected to grow Q/Q and Y/Y
  • Completed Strategic and Operational review
    • Differentiated portfolio investments focused on optimization, enhancement and expansion opportunities
    • Exploring potential divestitures...remaining price disciplined

(1) Refer to Appendix for complete Non-GAAP reconciliations of revenue, adjusted EBITDA. All metrics are adjusted to exclude divestitures.

3

Strategic & Operational Review Completed

Next steps to strengthen go-forward Company:

  • Investment Criteria for Business Units:
    • Optimize / Enhance / Expansion
  • Program management approach:
    • Disciplined transformation project plan / initiatives:
      • Growth
      • Quality
      • Efficiency
  • Possible Funding Alternatives:
    • Cash-on-hand
    • Revolver (target long-term net leverage ratio of 2.0x - 2.5x)
    • Possible divestitures or other strategic sources

4

Conduent Growth Approach

Optimize

Enhance

Expand

Increase retention and margin

Retain and grow through

Expand into current and adjacent markets

through productivity and better client

product enhancements

leveraging new technologies

outcomes

End-user Engagement

Gov't Healthcare

Commercial Healthcare

Transaction Processing

Human Resources Services(1)

Transportation

Gov't Services

Gov't Payments

Each business considered important with differing strategies for growth and disciplined investment

(1) Includes HR Outsourcing, BenefitWallet, and Learning.

Color Key:

Transportation

Commercial

Government5

Transformational Pillars Next Steps

GOALS

Growth

Retain every client, sell new business, market leadership

Quality

Consistent, high-quality service delivery

Efficiency

Simplified & standardized operating model

STRATEGY

  • Disciplined offering development
  • Brand & go-to-market repositioning
  • Expand salesforce talent
  • Client retention program
  • Standardize service delivery processes
  • Data center optimization
  • Command center
  • Technology modernization
  • Simplified & standardized operating model
  • Process improvement & governance
  • Associate engagement

SELECT METRICS

Revenue Retention

New Business Signings

SLA Performance

Severity 1 Outages

Client Satisfaction

AEBITDA Margin

Associate Retention

6

Financials

FY 2019 P&L Metrics

Revenue(1)

Adj. Operating Income(1)

$5,000M

$4,641M

$4,431M

$400M

$321M

$277M

(4.5)% Y/Y

(13.7)% Y/Y

$2,500M

(4.0)% in CC

$200M

$-M

FY '18

FY '19

$-M

FY '18

FY '19

GAAP:

$5,393M

$4,467M

GAAP:

$(395)M

$(2,106)M

Adj. EBITDA(1)

$750M

$535M

$493M

$500M

(7.9)% Y/Y

$250M

$-M

FY '18

FY '19

As Reported(2):

$640M

$494M

  • Revenue(1): down due to client attrition, price downs on renewals, volume pressure, and insufficient new business
  • Adj. Operating Income(1) and Adj. EBITDA(1): down due to revenue pressure, increased investment, partially offset by reduced IT, real estate, and corporate function spend
  • Adj. EBITDA Margin(1): 11.1%, down (40) bps Y/Y

(1)

Refer to Appendix for complete Non-GAAP reconciliations of revenue, adjusted operating income, and adjusted EBITDA/margin. These metrics are adjusted to exclude divestitures.

8

(2)

Includes divested businesses.

FY 2019 P&L by Segment

Revenue(1)

Adj EBITDA(1) Contributions

(6)% Y/Y

5% Y/Y

$157M

Transportation, $781M

$423M

7.1% Y/Y

8.2% in CC

(9)% Y/Y

$542M

$493M

Commercial, $2,385M

$(629)M

Government, $1,263M

(6.5)% Y/Y

Commercial Government Transportation Unallocated

Adjusted

(5.8)% in CC

(6.5)% Y/Y

Shared

EBITDA

Infrastructure

(6.5)% in CC

& Corporate

Costs

  • Commercial: decline driven by lost business, volume pressure, and price declines from renewals
  • Government: decline driven by lost business and price / scope changes associated with large renewal from 1H'19
  • Transportation: increase driven by new international transit business ramp and domestic tolling volume increases
  • Commercial: margin down (80) bps; AEBITDA decline primarily driven down by revenue, partially offset with reduced IT, labor, and RE
  • Government: margin up 10 bps; AEBITDA decline primarily driven down by revenue and partially offset by reduced IT
  • Transportation: margin down (30) bps; AEBITDA growth impacted positively by revenue and reduced IT
  • Unallocated shared costs: spend decreased 3% Y/Y

(1) Refer to Appendix for complete Non-GAAP reconciliations of revenue and adjusted EBITDA/margin. Revenue and Adjusted EBITDA exclude impact from divested operations.

9

Q4 / FY 2019 Cash Flow and Balance Sheet

FY Cash Balance

Balance Sheet

$765M $57M

$(118)M

$(19)M

$505M

$(180)M

Cash

Adjusted

Less

Less

Financing

Cash End

Beginning

Free Cash

Texas

Other

and

of Year

of Year

Flow (1)

Litigation

Adjustments

Investing

Payments

included

Cash Flow

in Adj FCF

(Less

CapEx)

  • Q4 / FY Adj. Free Cash Flow(1): $293M / $57M
  • Q4 / FY Capex as % of revenue: 5.2% / 4.8%
  • Revolver remains undrawn(2)

($ in millions)

12/31/2018

12/31/2019

Total Cash(3)

$765

$505

Total Debt(3)

1,567

1,514

Term Loan A(4,5) due 2022

705

664

Term Loan B(4) due 2023

833

824

10.5% Senior Notes due 2024

34

34

Capital Leases

26

17

Net adjusted leverage ratio(6)

1.2x

2.1x

Debt Maturity(5,7)

$1,000M

$800M

$750M

$571M

$500M

$250M

(1)

Refer to Appendix for complete non-GAAP reconciliations of Adjusted Free Cash Flow.

$50M

$84M

$34M

(2)

$667M of available capacity under Revolving Credit Facility as of December 31, 2019.

$-M

(3)

Total Cash includes $9M of restricted cash and Total debt excludes deferred financing costs.

2020

2021

2022

2023

2024

(4)

Revolving credit facility and Term Loan A interest rate is LIBOR + 175 bps; Term Loan B is LIBOR + 250 bps effective June

(5)

Term Loan A includes EUR 242M, converted to USD conversion rates on December 31, 2019.

(6)

Net debt (total debt less adjusted cash) divided by TTM Adjusted EBITDA (not adjusted for divestitures). Adjusted ratio uses total Debt which excludes deferred financing costs.

10

(7)

Debt maturity amounts exclude $17M of finance leases and $(25)M of debt issuance costs and unamortized discounts.

Key Sales Metrics

TCV Signings and Renewal Rate

New Business (ARR and NRR)

$1,800M

120%

$300M

92%

92%

93%

$1,200M

76%

90%

$200M

$57M

$906M

60%

$49M

$600M

$485M

60%

$100M

$140M

$43M

$42M

$621M

$727M

$512M

$506M

$32M

$328M

$84M

$71M

$74M

$225M

$234M

$209M

$52M

$-M

30%

$-M

Q1' 19

Q2' 19

Q3' 19

Q4' 19

Q4' 18

Q4' 18

Q1' 19

Q2' 19

Q3' 19

Q4' 19

New Business

Renewal

Renewal Rate

NB ARR Year 1

NB NRR

Renewals:

$30B

• Q4 2019: 76% (end-user engagement and tolling)

$20B

$18B

$20B

$18B

$22B

$21B

• FY 2019: 81% (impacted by California Medicaid)

New Business Signings TCV:

$12B

$12B

$10B

$12B

$11B

$10B

• Q4 2019: $209M, down (66)% Y/Y. Difficult compare

(signed large customer in Q4 2018)

Expect Q1'20 new business signings growth Q/Q and Y/Y

$-B

Q1' 19

Q2' 19

Q3' 19

Q4' 19

Pipeline:

Q4' 18

12 Month Rolling Pipeline

Cumulative Pipeline

Both total and 12-month stabilizing

Note: All metrics on page are adjusted to exclude divested operations as required.

11

FY 2020 Guidance

$ in Millions

Revenue

(Constant Currency)(1,2)

Adj. EBITDA / Adj. EBITDA Margin(2)

Adj. Free Cash Flow(2) as % of Adj. EBITDA

FY 2019

Completed

Adjusted FY

FY 2020

Divestiture

Reported

(4)

Guidance

Impact(3)

2019

$4.47B

$(36)M

$4.43B

Down (6) - (8)%

$494M

$(1)M

$493M / 11.1%

10.5% - 11.5%

12%15 - 20%

Guidance excludes incremental growth investment as a result of strategic review

Note: Please refer to the "Non-GAAP Outlook" in Appendix for certain non-GAAP information regarding outlook.

  1. Year-over-yearrevenue growth comparison at constant currency.
  2. Refer to Appendix for Non-GAAP reconciliations of revenue, adjusted EBITDA / margin and adjusted FCF and for impact from completed divestitures. FY 2019 adjusted FCF adjusted for Texas- related litigation and other specified items, but does not exclude cash generated from operations of businesses we have since divested.
  3. Includes all completed divestitures.

(4) Adjusted for completed divestitures referenced in Appendix.

12

Q&A

13

Appendix

14

Modeling Considerations

Metric

2020 Guidance

Taxes

Expect $50M - $60M in cash taxes for FY 2020 and adjusted tax rate of 29 - 32%

Restructuring

Expect ~$50M for FY 2020

Interest

Expect $70M - $75M for FY 2020 depending on interest rates

Texas Litigation Payments

Final $118M paid in January 2020

15

Q4 2019 P&L Metrics

Revenue(1)

Adj. Operating Income(1)

$1,500M

$150M

$1,178M

$1,099M

$98M

$1,000M

$100M

(6.7)% Y/Y

(24.0)% Y/Y

$74M

$500M

(6.5)% in CC

$50M

$-M

Q4 '18

Q4 '19

$-M

Q4 '18

Q4 '19

GAAP:

$1,282M

$1,099M

GAAP:

$(143)M

$(635)M

Adj. EBITDA(1)

$200M

$150M

$150M

$130M

$100M

(13.3)% Y/Y

$50M

$-M

Q4 '18

Q4 '19

As Reported(2):

$156M

$130M

  • Revenue(1): down due to client attrition, volume and price pressure, and insufficient new business
  • Adj. Operating Income(1) and Adj. EBITDA(1): down due to revenue pressure and increased investments
  • Adj. EBITDA Margin(1): 11.8%, down (90) bps Y/Y

(1)

Refer to Appendix for complete Non-GAAP reconciliations of revenue, adjusted operating income, and adjusted EBITDA/margin. These metrics are adjusted to exclude divestitures.

16

(2)

Includes divested businesses.

Q4 2019 P&L by Segment

Revenue(1)

Adj EBITDA(1) Contributions

(3)% Y/Y

(5)% Y/Y

Transportation, $202M

$38M

$113M

6.9% Y/Y

7.4% in CC

(12)% Y/Y

$145M

$130M

$(166)M

Commercial, $604M

Government, $292M

(7.1)% Y/Y

Commercial Government Transportation Unallocated

Adjusted

(6.8)% in CC

(13.4)% Y/Y

Shared

EBITDA

(13.4)% in CC

Infrastructure

& Corporate

Costs

  • Commercial: decline driven by lost business and volume pressure
  • Government: decline driven by ramp off of lost business and price and scope changes associated with large eligibility renewal that occurred earlier in 2019
  • Transportation: increase driven by new business ramp in international transit
  • Commercial: primarily driven down by revenue
  • Government: primarily driven down by revenue and partially offset by reduced IT spend
  • Transportation: impacted positively by revenue and reduced IT spend, offset by increased cost of delivery
  • Unallocated shared costs: of $(166)M, (1)% increased spend Y/Y

(1) Refer to Appendix for complete Non-GAAP reconciliations of revenue and adjusted EBITDA/margin. Revenue and Adjusted EBITDA exclude impact from divested operations.

17

Definitions

TCV: Total contract value. Signings are defined as estimated future revenues from contracts signed during the period, including renewals of existing contracts. Total Contract Value (TCV) is the estimated total contractual revenue related to signed contracts. Excludes the impact of divested business as required.

Renewal Rate: Annual recurring revenue (ARR) on contracts that are renewed during the period as a percentage of ARR on all contracts for which a renewal decision was made during the period (excluding contracts for which a strategic decision to not renew was made based on risk or profitability). Excludes the impact of divested business as required.

New Business Annual Recurring Revenue Year 1: Single year revenue amount of ARR for New Business. Excludes the impact of divested business as required.

New Business Non-Recurring Revenue: Total non-recurring revenue for New Business. Excludes the impact of divested business as required.

12 Month Rolling New Business Pipeline: New Business TCV pipeline of deals in all sell stages over a rolling 12 months. Excludes the impact of divested business as required.

Total New Business Pipeline: Total New Business TCV pipeline of deals in all sell stages. Extends past next 12 month period to include total pipeline. Excludes the impact of divested business as required.

18

Non-GAAP Financial Measures

Non-GAAP Financial Measures

We have reported our financial results in accordance with U.S. generally accepted accounting principles (GAAP). In addition, we have discussed our financial results using the non-GAAP measures. We believe these non- GAAP measures allow investors to better understand the trends in our business and to better understand and compare our results. Accordingly, we believe it is necessary to adjust several reported amounts, determined in accordance with U.S. GAAP, to exclude the effects of certain items as well as their related tax effects. Management believes that these non-GAAP financial measures provide an additional means of analyzing the results of the current period against the corresponding prior period. However, these non-GAAP financial measures should be viewed in addition to, and not as a substitute for, the Company's reported results prepared in accordance with U.S. GAAP. Our non-GAAP financial measures are not meant to be considered in isolation or as a substitute for comparable U.S. GAAP measures and should be read only in conjunction with our Consolidated Financial Statements prepared in accordance with U.S. GAAP. Our management regularly uses our supplemental non-GAAP financial measures internally to understand, manage and evaluate our business and make operating decisions, and providing such non-GAAP financial measures to investors allows for a further level of transparency as to how management reviews and evaluates our business results and trends. These non-GAAP measures are among the primary factors management uses in planning for and forecasting future periods. Compensation of our executives is based in part on the performance of our business based on certain of these non-GAAP measures.

A reconciliation of the following non-GAAP financial measures to the most directly comparable financial measures calculated and presented in accordance with U.S. GAAP are provided below.

These reconciliations also include the income tax effects for our non-GAAP performance measures in total, to the extent applicable. The income tax effects are calculated under the same accounting principles as applied to our reported pre-tax performance measures under ASC 740, which employs an annual effective tax rate method. The noted income tax effect for our non-GAAP performance measures is effectively the difference in income taxes for reported and adjusted pre-tax income calculated under the annual effective tax rate method. The tax effect of the non-GAAP adjustments was calculated based upon evaluation of the statutory tax treatment and the applicable statutory tax rate in the jurisdictions in which such charges were incurred.

Adjusted Net Income (Loss), Adjusted Earnings per Share and Adjusted Effective Tax Rate.

We make adjustments to Income (Loss) before Income Taxes for the following items as applicable to the particular measure, for the purpose of calculating Adjusted Revenue, Adjusted Net Income (Loss), Adjusted Earnings per Share and Adjusted Effective Tax Rate:

  • Amortization of acquired intangible assets. The amortization of acquired intangible assets is driven by acquisition activity, which can vary in size, nature and timing as compared to other companies within our industry and from period to period.
  • Restructuring and related costs. Restructuring and related costs include restructuring and asset impairment charges as well as costs associated with our strategic transformation program.
  • (Gain) loss on extinguishment of debt. Represents premium on debt extinguishment and the write down of the associated unamortized discount and issuance costs.
  • Goodwill impairment. This represents Goodwill impairment charge related to the unanticipated losses of certain customer contracts, lower potential future volumes and lower than expected new customer contracts for all reporting units.
  • (Gain) loss on divestitures and transaction costs. Represents (gain) loss on divested businesses and transaction costs.
  • Litigation costs (recoveries), net. Litigation costs (recoveries), net represents reserves for the State of Texas litigation, Student Loan Service exposures and certain significant terminated contracts that are subject to litigation.
  • Other charge (credit). This comprises other (income) expenses, net, costs associated with the Company not fully completing the State of New York Health Enterprise Platform project and the Health Enterprise Medical platform projects in California and Montana and other adjustments.
  • 2019 and 2018 divestitures. (Revenue) / (Income) loss from divestitures.

The Company provides adjusted net income and adjusted EPS financial measures to assist our investors in evaluating our ongoing operating performance for the current reporting period and, where provided, over different reporting periods, by adjusting for certain items which may be recurring or non-recurring and which in our view do not necessarily reflect ongoing performance. We also internally use these measures to assess our operating performance, both absolutely and in comparison to other companies, and in evaluating or making selected compensation decisions.

Management believes that adjusted effective tax rate, provided as supplemental information, facilitates a comparison by investors of our actual effective tax rate with an adjusted effective tax rate which reflects the impact of the items which are excluded in providing adjusted net income and certain other identified items, and may provide added insight into our underlying business results and how effective tax rates impact our ongoing business.

19

Non-GAAP Financial Measures

Adjusted Revenue, Adjusted Operating Income and Adjusted Operating Margin.

We make adjustments to Revenue, Costs and Expenses and Margin for the following items (as defined above), for the purpose of calculating Adjusted Revenue, Adjusted Operating Income and Adjusted Operating Margin:

  • Amortization of acquired intangible assets.
  • Restructuring and related costs.
  • Interest expense. Interest expense includes interest on long-term debt and amortization of debt issuance costs.
  • (Gain) loss on extinguishment of debt.
  • Goodwill impairment.
  • (Gain) loss on divestitures and transaction costs.
  • Litigation costs (recoveries), net.
  • Other charge (credit).
  • 2019 and 2018 divestitures.

We provide our investors with adjusted revenue, adjusted operating income and adjusted operating margin information, as supplemental information, because we believe it offers added insight, by itself and for comparability between periods, by adjusting for certain non-cash items as well as certain other identified items which we do not believe are indicative of our ongoing business, and may also provide added insight on trends in our ongoing business.

We provide adjusted revenues as supplemental information to our presentation of reported GAAP revenue in order to facilitate additional information to our investors concerning period-to-period comparisons reflecting the impact of our divestitures.

20

Non-GAAP Financial Measures

Consolidated Adjusted EBITDA and EBITDA Margin

We use Adjusted EBITDA and Adjusted EBITDA Margin as an additional way of assessing certain aspects of our operations that, when viewed with the U.S. GAAP results and the accompanying reconciliations to corresponding U.S. GAAP financial measures, provide a more complete understanding of our on-going business. Adjusted EBITDA represents Income (loss) before Interest, Income Taxes, Depreciation and Amortization and Contract Inducement Amortization adjusted for the following items (which are defined above). Adjusted EBITDA margin is Adjusted EBITDA divided by revenue or adjusted revenue, as applicable:

  • Restructuring and related costs.
  • (Gain) loss on extinguishment of debt.
  • Goodwill impairment.
  • (Gain) loss on divestitures and transaction costs.
  • Litigation costs (recoveries), net.
  • Other charge (credit).
  • 2019 and 2018 divestitures.

Adjusted EBITDA is not intended to represent cash flows from operations, operating income (loss) or net income (loss) as defined by U.S. GAAP as indicators of operating performance. Management cautions that amounts presented in accordance with Conduent's definition of Adjusted EBITDA and Adjusted EBITDA Margin may not be comparable to similar measures disclosed by other companies because not all companies calculate Adjusted EBITDA and EBITDA Margin in the same manner.

21

Non-GAAP Financial Measures

Free Cash Flow

Free Cash Flow is defined as cash flows from operating activities as reported on the consolidated statement of cash flows, less cost of additions to land, buildings and equipment, cost of additions to internal use software, tax payments related to divestitures, vendor financed capital lease and proceeds from sales of land, buildings and equipment. We use the non-GAAP measure of Free Cash Flow as a criterion of liquidity and performance-based components of employee compensation. We use Free Cash Flow as a measure of liquidity to determine amounts we can reinvest in our core businesses, such as amounts available to make acquisitions and invest in land, buildings and equipment and internal use software, after required payments on debt. In order to provide a meaningful basis for comparison, we are providing information with respect to our Free Cash Flow reconciled to cash flow provided by operating activities, which we believe to be the most directly comparable measure under U.S. GAAP.

Adjusted Free Cash Flow

Adjusted free cash flow is defined as Free Cash Flow from above plus deferred compensation payments, transaction costs, costs related to Texas litigation, and certain other identified adjustments. We use Adjusted Free Cash Flow, in addition to Free Cash Flow, to provide supplemental information to our investors concerning our ability to generate cash from our ongoing operating activities; by excluding certain deferred compensation costs and our one-time Texas settlement costs, as well as transaction costs and transaction cost tax benefit related to acquisitions, and debt buyback tax benefit, we believe we provide useful additional information to our investors to help them further understand our ability to generate cash period-over-period as well as added information on comparability to our competitors. Such as with Free Cash Flow information, as so adjusted, is specifically not intended to provide amounts available for discretionary spending. We have added certain adjustments to account for items which we do not believe reflect our core business or operating performance, and we computed all periods with such adjusted costs.

Constant Currency

To better understand trends in our business, we believe that it is helpful to adjust revenue to exclude the impact of changes in the translation of foreign currencies into U.S. Dollars. We refer to this adjusted revenue as "constant currency." Currency impact can be determined as the difference between actual growth rates and constant currency growth rates. This currency impact is calculated by translating the current period activity in local currency using the comparable prior-year period's currency translation rate.

Non-GAAP Outlook

In providing outlook for adjusted EBITDA we exclude certain items which are otherwise included in determining the comparable GAAP financial measure. A description of the adjustments which historically have been applicable in determining adjusted EBITDA are reflected in the table below. We are providing such outlook only on a non-GAAP basis because the Company is unable to predict with reasonable certainty the totality or ultimate outcome or occurrence of these adjustments for the forward-looking period, such as amortization, restructuring, NY MMIS, HE charge, goodwill impairment, and certain other adjusted items, which can be dependent on future events that may not be reliably predicted. Based on past reported results, where one or more of these items have been applicable, such excluded items could be material, individually or in the aggregate, to reported results. We have provided and outlook for revenue on a constant currency basis due to the inability to accurately predict foreign currency impact on revenues. Outlook for Free Cash Flow and Adjusted Free Cash Flow is provided as a factor of expected adjusted EBITDA, see above. For the same reason, we are unable to provide GAAP expected adjusted tax rate, which adjusts for our non-GAAP adjustments.

22

Non-GAAP Reconciliations: Adjusted Revenue, Adjusted Net Income (Loss), Adjusted Effective Tax, Adjusted Operating Income (Loss) and Adjusted EBITDA

(in millions)

Q4 2018

Q1 2019

Q2 2019

Q3 2019

Q4 2019

FY 2019

FY 2018

ADJUSTED REVENUE

Revenue

$

1,282

$

1,158

$

1,112

$

1,098

$

1,099

$

4,467

$

5,393

Adjustment:

2019 and 2018 divestitures(1)

(104)

(36)

-

-

-

(36)

(752)

Adjusted Revenue

$

1,178

$

1,122

$

1,112

$

1,098

$

1,099

$

4,431

$

4,641

ADJUSTED NET INCOME (LOSS)

Income (Loss) From Continuing Operations

$

(140)

$

(308)

$

(1,029)

$

(16)

$

(581)

$

(1,934)

$

(416)

Adjustments:

Amortization of acquired intangible assets(2)

61

62

61

61

62

246

242

Restructuring and related costs

13

16

26

8

21

71

81

(Gain) loss on extinguishment of debt

-

-

-

-

-

-

108

Goodwill impairment

-

284

1,067

-

601

1,952

-

(Gain) loss on divestitures and transaction costs

33

14

2

3

6

25

42

Litigation costs (recoveries), net

114

12

1

2

2

17

227

Other charges (credits)

3

(1)

5

(8)

(1)

(5)

2

Total Non-GAAP Adjustments

224

387

1,162

66

691

2,306

702

Income tax adjustments(3)

(26)

(47)

(103)

(13)

(69)

(232)

(56)

Adjusted Net Income (Loss) Before Adjustment for Divestitures

$

58

$

32

$

30

$

37

$

41

$

140

$

230

23

CONTINUED

(in millions)

Q4 2018

Q1 2019

Q2 2019

Q3 2019

Q4 2019

FY 2019

FY 2018

ADJUSTED EFFECTIVE TAX

Income (Loss) Before Income Taxes

$

(143)

$

(338)

$

(1,119)

$

(14)

$

(635)

$

(2,106)

$

(395)

Adjustment:

Total Non-GAAP Adjustments

224

387

1,162

66

691

2,306

702

Adjusted PBT (Before Adjustment for Divestitures)

81

49

43

52

56

200

307

2019 and 2018 divestitures(1)

(3)

(1)

-

-

-

(1)

(98)

Adjusted PBT

$

78

$

48

$

43

$

52

$

56

$

199

$

209

Income tax expense (benefit)

$

(3)

$

(30)

$

(90)

$

2

$

(54)

$

(172)

$

21

Income tax adjustments(3)

26

47

103

13

69

232

56

Adjusted Income Tax Expense (Benefit)

23

17

13

15

15

60

77

Adjusted Net Income (Loss) Before Adjustment for Divestitures

$

58

$

32

$

30

$

37

$

41

$

140

$

230

ADJUSTED OPERATING INCOME (LOSS)

Income (Loss) Before Income Taxes

$

(143)

$

(338)

$

(1,119)

$

(14)

$

(635)

$

(2,106)

$

(395)

Adjustment:

Total non-GAAP adjustments

224

387

1,162

66

691

2,306

702

Interest expense

20

20

20

20

18

78

112

Adjusted Operating Income (Loss) Before Adjustment for

101

69

63

72

74

278

419

Divestitures

2019 and 2018 divestitures(1)

(3)

(1)

-

-

-

(1)

(98)

Adjusted Operating Income (Loss)

$

98

$

68

$

63

$

72

$

74

$

277

$

321

24

CONTINUED

(in millions)

Q4 2018

Q1 2019

Q2 2019

Q3 2019

Q4 2019

FY 2019

FY 2018

ADJUSTED EBITDA

Income (Loss) From Continuing Operations

$

(140)

$

(308)

$

(1,029)

$

(16)

$

(581)

$

(1,934)

$

(416)

Income tax expense (benefit)

(3)

(30)

(90)

2

(54)

(172)

21

Depreciation and amortization

115

115

112

115

117

459

460

Contract inducement amortization

1

1

-

1

1

3

3

Interest expense

20

20

20

20

18

78

112

EBITDA Before Adjustment for Divestitures

(7)

(202)

(987)

122

(499)

(1,566)

180

2019 and 2018 divestitures(1)

(3)

(1)

-

-

-

(1)

(98)

2018 divestitures depreciation and amortization(1)

(3)

-

-

-

-

-

(7)

EBITDA

(13)

(203)

(987)

122

(499)

(1,567)

75

Adjustments:

Restructuring and related costs

13

16

26

8

21

71

81

(Gain) loss on extinguishment of debt

-

-

-

-

-

-

108

Goodwill impairment

-

284

1,067

-

601

1,952

-

(Gain) loss on divestitures and transaction costs

33

14

2

3

6

25

42

Litigation costs (recoveries), net

114

12

1

2

2

17

227

Other charges (credits)

3

(1)

5

(8)

(1)

(5)

2

Adjusted EBITDA Before Adjustment for Divestitures

$

156

$

123

$

114

$

127

$

130

$

494

$

640

Adjusted EBITDA

$

150

$

122

$

114

$

127

$

130

$

493

$

535

  1. Adjusted for the full impact from revenue and income/loss from divestitures for all periods presented.
  2. Included in Depreciation and amortization on the Consolidated Statements of Income (Loss).
  3. The tax impact of Adjusted Pre-tax income (loss) from continuing operations was calculated under the same accounting principles applied to the 'As Reported' pre-tax income (loss), which employs an annual effective tax rate method to the results and without regard to the business divestitures, the State of Texas litigation accrual, loss on extinguishment of debt, charges for amortization of intangible assets, restructuring, goodwill impairment and divestiture related costs.

25

Non-GAAP Reconciliations: Adjusted Weighted Average Shares Outstanding, Adjusted Diluted EPS, Adjusted Effective Tax, Adjusted Operating Margin and Adjusted EBITDA Margins for the Non-GAAP reconciliations

(Amounts are in whole dollars, shares are in thousands and margins are in %)

Q4 2018

Q1 2019

Q2 2019

Q3 2019

Q4 2019

FY 2019

FY 2018

ADJUSTED DILUTED EPS(1)

Weighted Average Common Shares Outstanding

207,103

207,944

208,496

209,626

211,190

209,318

206,056

Adjustments:

Stock options

45

27

7

-

-

-

97

Restricted stock and performance units / shares

3,480

2,783

2,814

1,509

2,106

2,157

3,481

Adjusted Weighted Average Common Shares Outstanding

210,628

210,754

211,317

211,135

213,296

211,475

209,634

Diluted EPS from Continuing Operations

$

(0.69)

$

(1.49)

$

(4.94)

$

(0.09)

$

(2.76)

$

(9.29)

$

(2.06)

Adjustments:

Total non-GAAP adjustments

1.07

1.85

5.56

0.31

3.26

11.01

3.38

Income tax adjustments(2)

(0.12)

(0.22)

(0.49)

(0.06)

(0.32)

(1.10)

(0.27)

Adjusted Diluted EPS Before Adjustment for Divestitures

$

0.26

$

0.14

$

0.13

$

0.16

$

0.18

$

0.62

$

1.05

ADJUSTED EFFECTIVE TAX RATE

Effective tax rate

2.1 %

8.9 %

8.0 %

(14.3)%

8.5 %

8.2 %

(5.3)%

Adjustments:

Total non-GAAP adjustments

26.3 %

25.8 %

22.2 %

43.1 %

18.3 %

21.8 %

30.4 %

Adjusted Effective Tax Rate(2)

28.4 %

34.7 %

30.2 %

28.8 %

26.8 %

30.0 %

25.1 %

26

CONTINUED

(Margins are in %)

Q4 2018

Q1 2019

Q2 2019

Q3 2019

Q4 2019

FY 2019

FY 2018

ADJUSTED OPERATING MARGIN

Income (Loss) Before Income Taxes Margin

(11.2)%

(29.2)%

(100.6)%

(1.3)%

(57.8)%

(47.1)%

(7.3)%

Adjustments:

Total non-GAAP adjustments

17.5 %

33.5 %

104.5 %

6.1 %

62.9 %

51.6 %

13.0 %

Interest expense

1.6 %

1.7 %

1.8 %

1.8 %

1.6 %

1.7 %

2.1 %

Margin for Adjusted Operating Income Before Adjustment for

7.9 %

6.0 %

5.7 %

6.6 %

6.7 %

6.2 %

7.8 %

Divestitures

2019 and 2018 divestitures(3)

0.4 %

0.1 %

- %

- %

- %

0.1 %

(0.9)%

Margin for Adjusted Operating Income

8.3 %

6.1 %

5.7 %

6.6 %

6.7 %

6.3 %

6.9 %

ADJUSTED EBITDA MARGIN

EBITDA Margin Before Adjustment for Divestitures

(0.5)%

(17.4)%

(88.8)%

11.1 %

(45.4)%

(35.1)%

3.3 %

2019 and 2018 divestitures(3)

(0.6)%

(0.7)%

- %

- %

- %

(0.3)%

(1.7)%

EBITDA Margin

(1.1)%

(18.1)%

(88.8)%

11.1 %

(45.4)%

(35.4)%

1.6 %

Total non-GAAP adjustments

12.7 %

28.0 %

99.1 %

0.5 %

57.2 %

46.2 %

8.6 %

2019 and 2018 divestitures(3)

0.6 %

0.7 %

- %

- %

- %

0.3 %

1.7 %

Adjusted EBITDA Margin Before Adjustment for Divestitures

12.2 %

10.6 %

10.3 %

11.6 %

11.8 %

11.1 %

11.9 %

2019 and 2018 divestitures(3)

0.5 %

0.3 %

- %

- %

- %

- %

(0.4)%

Adjusted EBITDA Margin

12.7 %

10.9 %

10.3 %

11.6 %

11.8 %

11.1 %

11.5 %

  1. Average shares for the 2019 and 2018 calculation of adjusted EPS excludes 5 million shares associated with our Series A convertible preferred stock and includes the impact of the preferred stock dividend of $3 million per each quarter.
  2. The tax impact of Adjusted Pre-tax income (loss) from continuing operations was calculated under the same accounting principles applied to the 'As Reported' pre-tax income (loss), which employs an annual effective tax rate method to the results and without regard to the business divestitures, the State of Texas litigation accrual, loss on extinguishment of debt, charges for amortization of intangible assets, restructuring, goodwill impairment and divestiture related costs.
  3. Adjusted for the full impact from revenue and income/loss from divestitures for all periods presented.

27

Non-GAAP Reconciliation: Adj. Free Cash Flow

Three Months Ended

Year Ended

December 31,

December 31,

(in millions)

2019

2018

2019

2018

Operating Cash Flow

$

348

$

253

$

132

$

283

Cost of additions to land, buildings and equipment

(39)

(60)

(148)

(179)

Proceeds from sales of land, buildings and equipment

-

1

2

13

Cost of additions to internal use software

(18)

(14)

(67)

(45)

Tax payment related to divestitures

1

50

9

90

Vendor financed capital leases

(3)

-

(3)

(14)

Free Cash Flow

$

289

$

230

$

(75)

$

148

Free Cash Flow

$

289

$

230

$

(75)

$

148

Transaction costs

1

14

14

33

Transaction costs tax benefit

3

(5)

-

(5)

Debt buyback tax benefit

-

(26)

-

(26)

Texas litigation payments

-

-

118

-

Deferred compensation tax benefit

-

(31)

-

(31)

Deferred compensation payments and adjustments

-

77

-

99

Adjusted Free Cash Flow

$

293

$

259

$

57

$

218

28

© 2017 Conduent Inc. All rights reserved. Conduent and Conduent Agile Star are trademarks of Conduent Inc. in the United States and/or other countries.

Attachments

Disclaimer

Conduent Inc. published this content on 21 February 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 21 February 2020 15:38:10 UTC